Layer 1

Pain rose during COVID-19 lockdown, Nurofen survey says

Sponsored

Backache, headache and joint pain rose among patients during lockdown, a survey commissioned by Nurofen has found.

The survey revealed that 36% of respondents reported increased backaches since the beginning of lockdown, out of the 2,000 responses that RWB gathered between July 31 and August 3 from people who experienced pain during lockdown.

The survey also indicated that fewer patients were able to speak to their pharmacist after lockdown was imposed, with 17% of respondents saying this, although the figure is five percentage points lower than that for GPs. 

The findings also revealed that 34% of respondents suffered more headaches, followed by 27% who flagged worsened joint pains, while 26% had more neck aches and 24% noted more muscle aches.

Some 60% of respondents wanted more advice on how to manage pain, the survey showed.

For more information on Nurofen products, visit the brand’s website

0 Comments
Question: 
Have you dispensed many painkillers since the beginning of lockdown?
Login or register to post comments

Job of the week

General Practice Pharmacist
Armagh, Dungannon, Newry
Up to £40,894